BCA
CELG

Bray Capital Advisors’s Celgene Corp CELG Stock Holding History

Bray Capital Advisors’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-8,352
Closed -$829K – 347
2019
Q3 		$829K Sell
8,352
-7,192
-46% -$683K 0.32% 74
2019
Q2 		$1.44M Sell
15,544
-1,410
-8% -$134K 0.55% 55
2019
Q1 		$1.6M Sell
16,954
-3,078
-15% -$269K 0.66% 46
2018
Q4 		$1.28M Buy
20,032
+4,393
+28% +$324K 0.64% 45
2018
Q3 		$1.4M Buy
15,639
+2,011
+15% +$178K 0.62% 51
2018
Q2 		$1.08M Buy
13,628
+1,612
+13% +$134K 0.5% 56
2018
Q1 		$1.07M Buy
12,016
+4,685
+64% +$450K 0.5% 54
2017
Q4 		$765K Sell
7,331
-2,654
-27% -$299K 0.37% 64
2017
Q3 		$1.46M Buy
9,985
+5,145
+106% +$701K 0.77% 50
2017
Q2 		$628K Buy
+4,840
New +$593K 0.34% 62
2015
Q4 		– Sell
-850
Closed -$92K – 383
2015
Q3 		$92K Buy
+850
New +$105K 0.06% 169

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Bray Capital Advisors's CELG Position: Q4 2019 in Review

Bray Capital Advisors sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 8,352 shares — an estimated $829K sold.

Bray Capital Advisors first reported a position in CELG in Q3 2015 and held it in 11 quarters. The position peaked at $1.6M in Q1 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Bray Capital Advisors reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Bray Capital Advisors sold 8,352 Celgene Corp shares in Q4 2019, an estimated $829K.
  • Bray Capital Advisors first reported a position in Celgene Corp in Q3 2015 and held it in 11 quarters.
  • Bray Capital Advisors's Celgene Corp position peaked at $1.6M in Q1 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Bray Capital Advisors's 13F filing for Q4 2019, filed 31 Jan 2020.